This compound is a pharmaceutical intermediate featuring a complex structure with multiple aromatic rings and halogen substituents. It is used in the synthesis of active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 877399-51-4
Krizotinib
active pharmaceutical ingredient
(S)-crizotinib
active pharmaceutical ingredient
Tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
Tert-butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
Pharmaceutical intermediate for synthesis
2,5-Pyridinedicarboxylic acid, 1,6-dihydro-6-oxo-, 2-ethyl ester
Pharmaceutical intermediate
Methyl 2-bromo-4-methylbenzoate
Pharmaceutical intermediate for synthetic chemistry
tert-butyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate
QDGJKKNXEBCNJI-OAHLLOKOSA-N
C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCN(CC4)C(=O)OC(C)(C)C)N